Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Estetrol · Nextstellis

Small molecule · developed by Mayne Pharma

Approved FDA
1 Registered trials

What is Estetrol?

Estetrol is an estrogen given orally as a tablet, and it is combined with drospirenone, a progestin, in a contraceptive.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
Nextstellis
Drug type
Small molecule
Pathways
ovulation suppression
Therapy area
Women's health
Developer
Mayne Pharma
In trials of
ICLR
FDA status
Approved as Nextstellis, NDA214154 · FDA label
UNII
ENB39R14VF

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT04090957 Phase 3 Vasomotor Symptoms Completed ICLR

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Menopausal SymptomsVasomotor Symptoms

Sources

Updated Nov 15, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.